Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion
Go back to Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1103.92 +1.84 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 255.54 | |||
| Day Low | $1079.22 | EPS | $4.32 | |||
| Volume | 1,289,675 | |||||

